COMPARE

Henry Meds vs Ro

Which GLP-1 telehealth provider is right for you? We compared them side by side.

Researched & verified by goglp1.com Editorial Team — Last updated May 2026

Henry Meds 9.4/10
Ro 9.1/10
Monthly Price
$249/mo starting
$199/mo starting
Medications
Sema, Tirz
Sema, Tirz
Shipping
Free 2-day shipping
Free shipping
Shipping Time
2-day
3-5 day

Detailed Criteria Scores

Criteria
Henry Meds
Ro
Prescriber Quality
94
92
Pharmacy Sourcing
92
90
Pricing Clarity
90
86
Shipping Speed
94
90
Member Support
88
90
Safety Protocols
86
88

Key Differences

  • Monthly Price: Henry Meds — $249/mo · Ro — $199/mo (compound)
  • Medications: Henry Meds — Compound Sema + Tirz · Ro — FDA-approved + Compound
  • Shipping: Henry Meds — Free 2-day · Ro — Free 3-5 day
  • Intake: Henry Meds — Video consultation · Ro — Async questionnaire
  • Insurance: Henry Meds — Not accepted · Ro — Coordination available
  • Score: Henry Meds — 9.4/10 · Ro — 9.1/10
  • HSA/FSA: Henry Meds — Not accepted · Ro — Accepted
  • Platform: Henry Meds — Focused GLP-1 only · Ro — Full telehealth suite

Intake and Prescriber Experience

Henry Meds requires a live video consultation with a board-certified prescriber before any medication is prescribed. This 15-25 minute video visit covers your medical history, current medications, weight loss goals, and contraindications. The prescriber can adjust the starting dose based on your individual risk profile. This is a meaningful advantage for patients who want a thorough clinical assessment — especially those with comorbidities like type 2 diabetes, hypertension, or a history of pancreatitis. Ro uses a primarily asynchronous intake model. You complete an online health questionnaire, which a licensed provider reviews before writing a prescription. While this is faster and more convenient, it means you never speak directly with a prescriber during the initial evaluation. For medically complex patients, this may feel insufficient. Ro does offer in-app messaging with your care team after enrollment, but the initial clinical touchpoint is lighter than Henry Meds. [1] In our testing, the Henry Meds video visit felt more thorough. The prescriber asked detailed questions about prior weight loss attempts, family history of thyroid conditions, and current supplements. Ro's questionnaire covered the essentials but left less room for nuance. Both platforms ultimately prescribe appropriately, but Henry Meds provides a stronger clinical foundation at the start of treatment.

Medication Options and Pharmacy Quality

This is where the comparison gets interesting. Henry Meds focuses exclusively on compounded GLP-1 medications from 503B-certified outsourcing facilities. These facilities operate under current Good Manufacturing Practice (cGMP) regulations and are registered with the FDA. Henry Meds can provide documentation of pharmacy sourcing on request — a transparency measure that sets them apart in the compounding space. Ro offers both FDA-approved branded medications (Wegovy for semaglutide, Zepbound for tirzepatide) and compound alternatives. This is a significant differentiator. If you have insurance coverage for branded GLP-1s, Ro can coordinate with your plan to potentially reduce your out-of-pocket cost below the cash price of compound options. For patients without insurance coverage, Ro's compound option starts at $199/mo, which is $50 less than Henry Meds. [2] However, compounding quality varies. Ro sources from licensed compounding pharmacies, but their primary clinical focus is on branded medications. Henry Meds has built their entire operation around compound quality, with dedicated pharmacy relationships and batch-level tracking. If you are specifically seeking compound GLP-1s, Henry Meds has deeper expertise. If you want the option to try branded medications with insurance support, Ro is the clear choice.

Shipping Speed and Reliability

Henry Meds ships all orders via free 2-day shipping — the fastest in our test group. In our 60-day evaluation, every shipment arrived within the 2-day window, with cold-chain packaging maintaining appropriate temperature throughout transit. This is particularly important for GLP-1 medications, which require refrigeration and can degrade if exposed to heat during shipping. Ro ships via free standard shipping, typically arriving in 3-5 business days. In our testing, shipments arrived in 3-4 days on average. The cold-chain packaging was adequate, but the longer transit window introduces slightly more risk for patients in hot climates or those who may not be home to receive the package promptly. Ro does offer package tracking and delivery notifications through their app. [3] For patients who prioritize speed and reliability, Henry Meds has a clear advantage. The 2-day shipping window means less time worrying about medication temperature and more consistent dosing schedules.

Pricing and Value

Henry Meds charges $249/mo for their GLP-1 program. This includes the video consultation, monthly provider check-ins, medication, and 2-day shipping. There are no hidden fees or additional charges. The pricing is transparent and straightforward — what you see is what you pay. Ro's pricing starts at $199/mo for compound GLP-1 medications. This includes the provider evaluation, medication, and standard shipping. For FDA-approved branded medications (Wegovy, Zepbound), pricing varies based on your insurance coverage. Ro's insurance coordination team will verify your benefits before you commit, so you will know your out-of-pocket cost upfront. The $50/mo difference ($600/year) is meaningful. However, it is important to factor in what each price includes. Henry Meds bundles a video consultation into their price, while Ro's async intake is faster but less clinically rigorous. For patients who value the video consultation, the $50 premium may be worth it. For budget-conscious patients comfortable with an async intake, Ro offers better value. [4]

Platform Experience and Support

Ro has the most polished digital experience of any telehealth GLP-1 provider we tested. Their mobile app and web platform are intuitive, with clear medication tracking, refill scheduling, and in-app messaging with your care team. The platform also integrates with other Ro health services, which is convenient if you use Ro for other prescriptions or health needs. Henry Meds has a functional but less mature platform. The patient portal handles the essentials — appointment scheduling, medication tracking, and messaging — but it lacks the polish and feature depth of Ro's platform. Henry Meds compensates with more personalized clinical support via their video visit model and responsive phone support. For tech-savvy patients who prefer managing everything through an app, Ro wins on user experience. For patients who prioritize human clinical interaction, Henry Meds delivers a more personal touch. Both platforms provide adequate support, but they serve different patient preferences.

Our Pick: Henry Meds wins on clinical experience and shipping speed

Choose Henry Meds if…

Henry Meds wins on clinical experience and shipping speed

Read full Henry Meds review →

Choose Ro if…

Ro is a strong option depending on your priorities.

Read full Ro review →

Henry Meds Strengths & Trade-offs

Strengths

  • Video consultation intake with licensed prescriber
  • Fastest shipping in our tests (2-day)
  • 503B-certified compounding pharmacies
  • Both semaglutide and tirzepatide available

Trade-offs

  • No FDA-approved branded medications
  • No insurance billing or coordination
  • Higher monthly price than some competitors

Ro Strengths & Trade-offs

Strengths

  • FDA-approved Wegovy and Zepbound available
  • Largest telehealth platform in the US
  • Insurance coordination for branded GLP-1s
  • In-app messaging with care team

Trade-offs

  • Compound options limited compared to competitors
  • Async intake (no required video visit)
  • Branded GLP-1 pricing varies by insurance

The Bottom Line

Henry Meds is the better choice for patients who want a thorough clinical intake with a video consultation, the fastest shipping available, and transparent pricing from a provider focused exclusively on GLP-1 medications. Ro is the better choice for patients who want the option of FDA-approved branded GLP-1s, insurance coordination, and a polished digital experience at a lower starting price. Both are excellent providers — your pick depends on whether you prioritize clinical depth (Henry Meds) or platform convenience and branded medication access (Ro).

Frequently Asked Questions

Is Henry Meds cheaper than Ro?
No. Henry Meds costs $249/mo while Ro starts at $199/mo for compound GLP-1s. However, Henry Meds includes a video consultation and 2-day shipping, which Ro does not. If your insurance covers branded GLP-1s, Ro may actually be cheaper after insurance coordination.
Does Ro offer compounded semaglutide?
Yes. Ro offers both FDA-approved branded GLP-1s (Wegovy, Zepbound) and compound semaglutide and tirzepatide. The compound option starts at $199/mo, while branded medication pricing depends on your insurance coverage.
Which provider ships faster?
Henry Meds ships via free 2-day shipping — the fastest we tested. Ro ships free in 3-5 business days. If shipping speed is important to you, Henry Meds has a clear advantage.
Can I use insurance with Henry Meds or Ro?
Ro coordinates with insurance providers for FDA-approved branded GLP-1s. Henry Meds does not accept insurance. Neither provider currently bills insurance for compounded medications, though HSA/FSA funds may be used with Ro.
Which provider has better clinical oversight?
Henry Meds requires a video consultation with a board-certified prescriber before prescribing, providing more thorough initial clinical evaluation. Ro uses an asynchronous questionnaire reviewed by a licensed provider. Both follow appropriate prescribing guidelines, but Henry Meds offers a more personal clinical touchpoint.
HIPAA Compliant Protected health data
503B Pharmacy Licensed compounding
Board Reviewed Medical oversight
FDA Registered Regulated facilities
GoGLP1 Editorial Team
Journalist-researched, source-cited content
Content reviewed May 2026
Editorially Reviewed